The earlier SUSTAIN dose-finding studies for diabetes (Nauck et al., Diabetes Care, 2016) tested multiple dose levels including 0.05 mg, 0.1 mg, 0.2 mg, 0.3 mg, and 0.4 mg daily (note: daily, not weekly) of oral semaglutide and found dose-dependent reductions in HbA1c and body weight at every dose tested
Semaglutide offers several benefits for people with diabetes or those looking to lose weight: Improved Blood Sugar Control: By helping your body manage insulin and blood sugar, semaglutide reduces the risk of complications related to diabetes, such as heart disease, kidney failure, and nerve damage
Verify current LegitScript status directly at LegitScript.com
MGCPQQ is a registered trademark of MGC (Japan)
The confidence to be more active